The U.S. Patent and Trademark Office has granted Anavex Life Sciences a patent covering nerve protection treatments that combine…
Magdalena Kegel
Magdalena is a writer with a passion for bridging the gap between the people performing research, and those who want or need to understand it. She writes about medical science and drug discovery. She holds an MS in Pharmaceutical Bioscience and a PhD — spanning the fields of psychiatry, immunology, and neuropharmacology — from Karolinska Institutet in Sweden.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Magdalena Kegel
Canadian researchers are working on the creation of a virtual assistant that could help people with Alzheimer’s disease do a…
Alzheimer’s disease leaves traces in the white blood cells of its patients that could be used to diagnose the disease.
Aducanumab reduced deposits of the amyloid plaque associated with Alzheimer’s disease in the brains of early-stage patients who took part…
Increasing the intake of trace amounts of lithium over a long period may prevent…
In the future, doctors may diagnose Alzheimer’s disease by scanning a patient’s eyes — thanks to new evidence that telltale plaques of…
A lack of energy in brain cells called microglia might explain why people with mutations in the TREM2 gene are…
National Football League athletes might be at increased risk of chronic traumatic encephalopathy (CTE), a brain condition linked to dementia…
Controlling How Enzyme Cuts Protein Linked to Alzheimer’s Could Prevent Disease, Study Suggests
A single amino acid can determine where an enzyme cuts a precursor to the amyloid beta protein — and the…
A compound that blocks the activity of so-called HDAC enzymes in the brain improved learning in mouse models of Alzheimer’s disease,…